Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TENX |
---|---|---|
09:32 ET | 89259 | 1.7192 |
09:33 ET | 58717 | 1.71 |
09:35 ET | 27857 | 1.71 |
09:37 ET | 78620 | 1.705 |
09:39 ET | 59078 | 1.7099 |
09:42 ET | 25861 | 1.745 |
09:44 ET | 45127 | 1.735 |
09:46 ET | 20646 | 1.77 |
09:48 ET | 33657 | 1.7787 |
09:50 ET | 11802 | 1.76 |
09:51 ET | 26674 | 1.765 |
09:53 ET | 252777 | 1.6778 |
09:55 ET | 40465 | 1.68 |
09:57 ET | 81255 | 1.69 |
10:00 ET | 65842 | 1.68 |
10:02 ET | 15950 | 1.6801 |
10:04 ET | 19806 | 1.685 |
10:06 ET | 16494 | 1.6886 |
10:08 ET | 13427 | 1.69 |
10:09 ET | 23655 | 1.6887 |
10:11 ET | 12326 | 1.685 |
10:13 ET | 9910 | 1.69 |
10:15 ET | 11814 | 1.685 |
10:18 ET | 25848 | 1.73 |
10:20 ET | 8675 | 1.73 |
10:22 ET | 20059 | 1.6999 |
10:24 ET | 19478 | 1.685 |
10:26 ET | 12566 | 1.6929 |
10:27 ET | 5556 | 1.69 |
10:29 ET | 16324 | 1.7 |
10:31 ET | 9945 | 1.6999 |
10:33 ET | 9799 | 1.7 |
10:36 ET | 14031 | 1.695 |
10:38 ET | 26212 | 1.69 |
10:40 ET | 7444 | 1.7 |
10:42 ET | 2582 | 1.695 |
10:44 ET | 8478 | 1.69 |
10:45 ET | 12384 | 1.6999 |
10:47 ET | 46859 | 1.6998 |
10:49 ET | 18862 | 1.69 |
10:51 ET | 7933 | 1.7 |
10:54 ET | 2350 | 1.6999 |
10:56 ET | 10970 | 1.6996 |
10:58 ET | 6796 | 1.695 |
11:00 ET | 3700 | 1.7 |
11:02 ET | 15700 | 1.6913 |
11:03 ET | 8686 | 1.69 |
11:05 ET | 28489 | 1.7 |
11:07 ET | 42105 | 1.7 |
11:09 ET | 77653 | 1.7428 |
11:12 ET | 33517 | 1.755 |
11:14 ET | 59557 | 1.76 |
11:16 ET | 135833 | 1.85 |
11:18 ET | 83213 | 1.85 |
11:20 ET | 61434 | 1.815 |
11:21 ET | 16823 | 1.805 |
11:23 ET | 14576 | 1.7897 |
11:25 ET | 21207 | 1.755 |
11:27 ET | 6247 | 1.76 |
11:30 ET | 17479 | 1.79 |
11:32 ET | 11118 | 1.7885 |
11:34 ET | 26251 | 1.77 |
11:36 ET | 10467 | 1.76 |
11:38 ET | 8095 | 1.76 |
11:39 ET | 1587 | 1.77 |
11:41 ET | 13490 | 1.77 |
11:43 ET | 3018 | 1.7684 |
11:45 ET | 8567 | 1.77 |
11:48 ET | 15977 | 1.765 |
11:50 ET | 8875 | 1.765 |
11:52 ET | 1700 | 1.7671 |
11:54 ET | 4014 | 1.77 |
11:56 ET | 105803 | 1.71 |
11:57 ET | 15636 | 1.708 |
11:59 ET | 4086 | 1.705 |
12:01 ET | 11613 | 1.71 |
12:03 ET | 14600 | 1.7187 |
12:06 ET | 9784 | 1.72 |
12:08 ET | 26426 | 1.74 |
12:10 ET | 13319 | 1.7483 |
12:12 ET | 123731 | 1.7 |
12:14 ET | 70065 | 1.7188 |
12:15 ET | 14927 | 1.725 |
12:17 ET | 18265 | 1.74 |
12:19 ET | 15885 | 1.7593 |
12:21 ET | 8129 | 1.75 |
12:24 ET | 11233 | 1.75 |
12:26 ET | 15303 | 1.75 |
12:28 ET | 6672 | 1.755 |
12:30 ET | 4859 | 1.76 |
12:32 ET | 5715 | 1.75 |
12:33 ET | 6778 | 1.7507 |
12:35 ET | 13336 | 1.755 |
12:37 ET | 90640 | 1.76 |
12:39 ET | 13600 | 1.7509 |
12:42 ET | 2242 | 1.7501 |
12:44 ET | 17613 | 1.76 |
12:46 ET | 14903 | 1.7515 |
12:48 ET | 6681 | 1.75 |
12:50 ET | 1523 | 1.7598 |
12:51 ET | 4587 | 1.7599 |
12:53 ET | 6633 | 1.76 |
12:55 ET | 2145 | 1.755 |
12:57 ET | 700 | 1.75 |
01:00 ET | 2084 | 1.75 |
01:02 ET | 5550 | 1.76 |
01:04 ET | 11807 | 1.75 |
01:06 ET | 2443 | 1.7514 |
01:08 ET | 15452 | 1.755 |
01:09 ET | 1850 | 1.755 |
01:11 ET | 1331 | 1.755 |
01:13 ET | 7402 | 1.7545 |
01:15 ET | 1177 | 1.75 |
01:18 ET | 6959 | 1.75 |
01:20 ET | 3280 | 1.7587 |
01:22 ET | 1283 | 1.76 |
01:24 ET | 2426 | 1.76 |
01:26 ET | 27327 | 1.76 |
01:27 ET | 14892 | 1.75 |
01:29 ET | 3140 | 1.7529 |
01:31 ET | 20596 | 1.75 |
01:33 ET | 28927 | 1.755 |
01:36 ET | 4131 | 1.755 |
01:38 ET | 33259 | 1.76 |
01:40 ET | 15254 | 1.76 |
01:42 ET | 3658 | 1.765 |
01:44 ET | 10080 | 1.775 |
01:45 ET | 3942 | 1.77 |
01:47 ET | 3599 | 1.78 |
01:49 ET | 6902 | 1.76 |
01:51 ET | 382 | 1.7588 |
01:54 ET | 12072 | 1.75 |
01:56 ET | 1324 | 1.755 |
01:58 ET | 3958 | 1.755 |
02:00 ET | 50111 | 1.75 |
02:02 ET | 2579 | 1.75 |
02:03 ET | 11085 | 1.76 |
02:05 ET | 1670 | 1.755 |
02:07 ET | 39677 | 1.765 |
02:09 ET | 2300 | 1.76 |
02:12 ET | 2300 | 1.765 |
02:14 ET | 2414 | 1.7601 |
02:16 ET | 1350 | 1.765 |
02:18 ET | 700 | 1.765 |
02:20 ET | 2799 | 1.76 |
02:21 ET | 9771 | 1.77 |
02:23 ET | 4622 | 1.7511 |
02:25 ET | 440 | 1.755 |
02:27 ET | 2118 | 1.76 |
02:30 ET | 1600 | 1.75 |
02:32 ET | 5999 | 1.755 |
02:34 ET | 300 | 1.76 |
02:36 ET | 1250 | 1.76 |
02:38 ET | 400 | 1.76 |
02:39 ET | 822 | 1.76 |
02:41 ET | 6586 | 1.75 |
02:43 ET | 14696 | 1.755 |
02:45 ET | 9763 | 1.75 |
02:48 ET | 2300 | 1.75 |
02:50 ET | 2754 | 1.755 |
02:52 ET | 4980 | 1.755 |
02:54 ET | 2650 | 1.76 |
02:56 ET | 800 | 1.755 |
02:57 ET | 2863 | 1.75 |
02:59 ET | 14014 | 1.755 |
03:01 ET | 3620 | 1.7501 |
03:03 ET | 909 | 1.75 |
03:06 ET | 865 | 1.76 |
03:08 ET | 6373 | 1.75 |
03:10 ET | 400 | 1.76 |
03:12 ET | 6100 | 1.755 |
03:14 ET | 1143 | 1.7599 |
03:15 ET | 9823 | 1.75 |
03:17 ET | 5391 | 1.75 |
03:19 ET | 2202 | 1.7585 |
03:21 ET | 20127 | 1.755 |
03:24 ET | 12018 | 1.7593 |
03:26 ET | 18130 | 1.755 |
03:28 ET | 14891 | 1.75 |
03:30 ET | 6181 | 1.76 |
03:32 ET | 37291 | 1.75 |
03:33 ET | 6300 | 1.75 |
03:35 ET | 2000 | 1.76 |
03:37 ET | 16325 | 1.75 |
03:39 ET | 5187 | 1.76 |
03:42 ET | 900 | 1.76 |
03:44 ET | 7483 | 1.755 |
03:46 ET | 28935 | 1.77 |
03:48 ET | 13201 | 1.775 |
03:50 ET | 25109 | 1.77 |
03:51 ET | 33061 | 1.79 |
03:53 ET | 13298 | 1.8 |
03:55 ET | 23800 | 1.78 |
03:57 ET | 9768 | 1.77 |
04:00 ET | 34495 | 1.75 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Tenax Therapeutics Inc | 4.0M | -3.6x | --- |
LadRx Corp | 3.8M | -0.3x | --- |
Palisade Bio Inc | 4.2M | -0.1x | --- |
Dermata Therapeutics Inc | 3.7M | -0.2x | --- |
Vallon Pharmaceuticals Inc | 3.6M | -0.3x | --- |
Ampio Pharmaceuticals Inc | 4.5M | -0.2x | --- |
Tenax Therapeutics, Inc. is a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need. The Company's products include TNX-103 (oral levosimendan) and TNX-201 (oral enteric coated imatinib). The Company's lead product, Levosimendan, is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure. TNX-201 is for the treatment of pulmonary arterial hypertension (PAH), which is a fatal orphan disease. The Company has completed Phase II clinical trial of levosimendan in North America for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.0M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 2.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.03 |
EPS | $-0.48 |
Book Value | $0.17 |
P/E Ratio | -3.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.